Docoh
Loading...

11 results

Filter options loading...
Top filers
Top filing types
Recent filing years
DEF 14A
PCSA Processa Pharmaceuticals Inc
22 Apr 21
Definitive proxy
2:00pm
, including independent directors, designed to ensure the powers and duties of the dual role are handled responsibly. We do not have a lead independent director. Our
10-K/A
2020 FY
PCSA Processa Pharmaceuticals Inc
7 Apr 21
Annual report (amended)
4:23pm
responsibly. We do not have a lead independent director. Our Board of Directors oversees the management of risks inherent in the operation of our
424B4
PCSA Processa Pharmaceuticals Inc
5 Oct 20
Prospectus supplement with pricing info
4:16pm
of the dual role are handled responsibly. We do not have a lead independent director. Our Board of Directors oversees the management of risks inherent
S-1/A
PCSA Processa Pharmaceuticals Inc
30 Sep 20
IPO registration (amended)
4:06pm
, including independent directors, designed to ensure the powers and duties of the dual role are handled responsibly. We do not have a lead independent director. Our
S-1/A
PCSA Processa Pharmaceuticals Inc
16 Sep 20
IPO registration (amended)
8:00pm
, including independent directors, designed to ensure the powers and duties of the dual role are handled responsibly. We do not have a lead independent director. Our
S-1/A
EX-3.2
5fvudxd1 nf
16 Sep 20
IPO registration (amended)
8:00pm
S-1/A
mgih5szfoplgz3n3i1z
17 Jul 20
IPO registration (amended)
5:25pm
10-K
0i3pbv zod40mt
5 Mar 20
Annual report
7:00pm
S-1
mvus67a zeo
13 Dec 19
IPO registration
5:32pm
10-K
EX-3.2
y1fdxck2k o4qbi
26 Mar 14
Annual report
8:00pm
S-1
EX-3
wex8ftyogk58m0wbu1b
13 Nov 12
IPO registration
7:00pm
  • 1